Table 2.
Clinical data of patients who received stings I.
| Number of patients | 37 |
| Sex | |
| Males | 23 (62.2%) |
| Females | 14 (37.8%) |
| Middle age (years) | 28 |
| Range (years) | 8 – 52 |
| Grade of sting* | |
| I | 3 (8.1%) |
| II | 13 (35.1%) |
| III–IV | 21 (56.8%) |
| Intra-cutaneous tests | |
| Lowest concentration eliciting the diagnosis | |
| 0.01 ìg/ml | 12 (32.4%) |
| 0.1 μg/ml | 24 (64.9%) |
| 1 μg/ml | 1 (2.7%) |
| Medication required | |
| Adrenaline | 15 (45.4%) |
| Antihistamines | 7 (21.2%) |
| Adr. + Antihist | 5 (15.2%) |
| Both + Glucocorticoides | 1 (3.0%) |
| No medication required | 5 (15.2%) |
* Classified according to Mueller [11]: Grade I – urticaria, pruritus, malaise; Grade II – angioedema, chest tightness, nausea, vomiting, abdominal pain, dizziness; Grade III – dispnoea, wheeze, stridor, dysphagia, hoarseness; Grade IV – hypotension, collapse, loss of consciousness, incontinence, cyanosis.